Elizabeth Yeu Lin
CIK: 0001842190
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (23 total)
- Sep 4, 2026TARS
Tarsus Pharmaceuticals, Inc.
Sale(S)Indirect1.6K shares at avg. $90.00$143K - Sep 4, 2026TARS
Tarsus Pharmaceuticals, Inc.
Sale(S)Direct5.4K shares at avg. $85.00$458K - Sep 4, 2026TARS
Tarsus Pharmaceuticals, Inc.
Sale(S)Direct5.4K shares at avg. $90.00$485K - Sep 4, 2026TARS
Tarsus Pharmaceuticals, Inc.
Sale(S)Indirect1.6K shares at avg. $85.00$135K - Sep 2, 2026TARS
Tarsus Pharmaceuticals, Inc.
Sale(S)Indirect1.6K shares at avg. $80.00$127K - Sep 2, 2026TARS
Tarsus Pharmaceuticals, Inc.
Sale(S)Direct5.4K shares at avg. $80.00$431K - Sep 1, 2026TARS
Tarsus Pharmaceuticals, Inc.
Sale(S)Direct4.6K shares at avg. $73.86$340K - Mar 19, 2026TARS
Tarsus Pharmaceuticals, Inc.
Sale(S)Direct390 shares at avg. $67.00$26K - Mar 18, 2026TARS
Tarsus Pharmaceuticals, Inc.
Sale(S)Direct379 shares at avg. $68.71$26K - Mar 17, 2026TARS
Tarsus Pharmaceuticals, Inc.
Sale(S)Direct375 shares at avg. $69.42$26K - Mar 15, 2026TARS
Tarsus Pharmaceuticals, Inc.
Exercise(M)Direct2.5K shares- - Mar 5, 2026TARS
Tarsus Pharmaceuticals, Inc.
Award(A)DirectRestricted Stock Units
17.2K shares- - Mar 5, 2026TARS
Tarsus Pharmaceuticals, Inc.
Award(A)DirectStock Option (right to buy)
27.3K shares- - Dec 16, 2025TARS
Tarsus Pharmaceuticals, Inc.
Sale(S)Direct2.1K shares at avg. $79.50$165K - Dec 15, 2025TARS
Tarsus Pharmaceuticals, Inc.
Exercise(M)Direct6.8K shares- - Jun 18, 2025STAA
STAAR SURGICAL CO
Award(A)DirectRestricted Stock Units
5.3K shares- - Jun 18, 2025STAA
STAAR SURGICAL CO
Award(A)DirectCommon Stock Options
9.7K shares- - Jun 16, 2025TARS
Tarsus Pharmaceuticals, Inc.
Sale(S)Direct1K shares at avg. $41.08$41K - Jun 13, 2025TARS
Tarsus Pharmaceuticals, Inc.
Exercise(M)Direct3.4K shares- - Mar 5, 2025TARS
Tarsus Pharmaceuticals, Inc.
Award(A)DirectRestricted Stock Units
10K shares- - Mar 5, 2025TARS
Tarsus Pharmaceuticals, Inc.
Award(A)DirectStock Option (right to buy)
15.3K shares- - Nov 4, 2024TARS
Tarsus Pharmaceuticals, Inc.
Award(A)DirectStock Option (right to buy)
41.1K shares- - Nov 4, 2024TARS
Tarsus Pharmaceuticals, Inc.
Award(A)DirectRestricted Stock Units
27.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 4, 2026 |  TARS Tarsus Pharmaceuticals, Inc. | Sale(S) | 1,590 | $90.00 | $143,100 | Indirect |
| Sep 4, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale(S) | 5,387 | $85.00 | $457,895 | Direct |
| Sep 4, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale(S) | 5,386 | $90.00 | $484,740 | Direct |
| Sep 4, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale(S) | 1,590 | $85.00 | $135,150 | Indirect |
| Sep 2, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale(S) | 1,590 | $80.00 | $127,200 | Indirect |
| Sep 2, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale(S) | 5,387 | $80.00 | $430,960 | Direct |
| Sep 1, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale(S) | 4,601 | $73.86 | $339,830 | Direct |
| Mar 19, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale(S) | 390 | $67.00 | $26,130 | Direct |
| Mar 18, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale(S) | 379 | $68.71 | $26,041 | Direct |
| Mar 17, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Sale(S) | 375 | $69.42 | $26,033 | Direct |
| Mar 15, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Exercise(M) | 2,511 | - | $0 | Direct |
| Mar 5, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Award(A) Restricted Stock Units | 17,161 | - | - | Direct |
| Mar 5, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Award(A) Stock Option (right to buy) | 27,310 | - | - | Direct |
| Dec 16, 2025 | TARS Tarsus Pharmaceuticals, Inc. | Sale(S) | 2,078 | $79.50 | $165,201 | Direct |
| Dec 15, 2025 | TARS Tarsus Pharmaceuticals, Inc. | Exercise(M) | 6,819 | - | - | Direct |
| Jun 18, 2025 |  STAA STAAR SURGICAL CO | Award(A) Restricted Stock Units | 5,341 | - | - | Direct |
| Jun 18, 2025 | STAA STAAR SURGICAL CO | Award(A) Common Stock Options | 9,708 | - | - | Direct |
| Jun 16, 2025 | TARS Tarsus Pharmaceuticals, Inc. | Sale(S) | 1,006 | $41.08 | $41,326 | Direct |
| Jun 13, 2025 | TARS Tarsus Pharmaceuticals, Inc. | Exercise(M) | 3,350 | - | - | Direct |
| Mar 5, 2025 | TARS Tarsus Pharmaceuticals, Inc. | Award(A) Restricted Stock Units | 10,045 | - | - | Direct |
| Mar 5, 2025 | TARS Tarsus Pharmaceuticals, Inc. | Award(A) Stock Option (right to buy) | 15,314 | - | - | Direct |
| Nov 4, 2024 | TARS Tarsus Pharmaceuticals, Inc. | Award(A) Stock Option (right to buy) | 41,074 | - | - | Direct |
| Nov 4, 2024 | TARS Tarsus Pharmaceuticals, Inc. | Award(A) Restricted Stock Units | 27,278 | - | - | Direct |
1-23 of 23 transactions
About Lin Elizabeth Yeu
Lin Elizabeth Yeu (SEC CIK 0001842190) files insider reports with the SEC as Chief Medical Officer of Tarsus Pharmaceuticals, Inc. (TARS) and Director of STAAR SURGICAL CO (STAA).
Signal8 holds 10 ownership filings by Lin Elizabeth Yeu, all Form 4s, filed between Nov 6, 2024 and Sep 9, 2026. Those filings report 23 transactions, from Nov 4, 2024 to Sep 4, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Lin Elizabeth Yeu's filings is in IRVINE, CA.
Recent filings by Lin Elizabeth Yeu
- Sep 4, 2026: Open-market sales of TARS shares (4 lines, Form 4, code S).
- Sep 2, 2026: Open-market sales of TARS shares (2 lines, Form 4, code S).
- Sep 1, 2026: Open-market sale of TARS shares (Form 4, code S).
- Mar 19, 2026: Open-market sale of TARS shares (Form 4, code S).
- Mar 18, 2026: Open-market sale of TARS shares (Form 4, code S).
Other insiders filing for Tarsus Pharmaceuticals, Inc. (TARS)
- PYOTT DAVID E I, Director
- YARNO WENDY L, Director
- LINK WILLIAM J PHD, Director
- Azamian Bobak R., President/CEO and Board Chair
- Neervannan Seshadri, Chief Operating Officer
- Goodrich Katherine, Director